Efficacy and Safety of HDM1005 Compared to Tirzepatide in Obese Adults Without Diabetes

NCT07521631 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

372

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: HDM1005 dose level 1
DRUG: HDM1005 dose level 2
DRUG: HDM1005 dose level 3
DRUG: Tirzepatide

Sponsor

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.